SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-021636
Filing Date
2024-08-19
Accepted
2024-08-19 18:56:04
Documents
1
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 form3-08192024_100800.html 3  
1 form3-08192024_100800.xml 3 3499
  Complete submission text file 0001415889-24-021636.txt   5203
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address
Hackman Jeffrey S. (Reporting) CIK: 0001926254 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32295 | Film No.: 241222201